Excelart boasts CV imaging

Article

Cardiovascular capabilities available on Toshiba's ultracompact high-field MR system were highlighted at the annual meeting of the American College of Cardiology, March 7 to 10 in New Orleans. Vantage, which was formally released at the 2003 RSNA

Cardiovascular capabilities available on Toshiba's ultracompact high-field MR system were highlighted at the annual meeting of the American College of Cardiology, March 7 to 10 in New Orleans. Vantage, which was formally released at the 2003 RSNA meeting, supports a range of CV studies from stroke evaluation to peripheral vascular imaging. The ultrashort bore provides a feeling of openness; Pianissimo technology reduces scan noise. SuperFASE supports morphology studies of vascular structures, including the heart chambers and large vessels, as well as MR angiograms of venous and arterial vessels. Toshiba's parallel imaging technology, called Speeder, allows high-speed, high-resolution imaging, cutting exam time by as much as a factor of three.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.